Kidney International
Journal
-
- Overview
-
- Identity
-
- View All
-
Overview
publication venue for
-
The authors reply.
103:1201-1201.
2023
-
A novel direct adenosine monophosphate kinase activator ameliorates disease progression in preclinical models of Autosomal Dominant Polycystic Kidney Disease.
103:917-929.
2023
-
Effects of aspirin on cardiovascular outcomes in patients with chronic kidney disease.
103:403-410.
2023
-
Defining measures of kidney function in observational studies using routine health care data: methodological and reporting considerations.
103:53-69.
2023
-
PHYOX2: a pivotal randomized study of nedosiran in primary hyperoxaluria type 1 or 2.
103:207-217.
2023
-
Barriers to accessing essential medicines for kidney disease in low- and lower middle–income countries|.
102:969-973.
2022
-
GLP-1 receptor agonist versus DPP-4 inhibitor and kidney and cardiovascular outcomes in clinical practice in type-2 diabetes.
101:360-368.
2022
-
Anticoagulation in patients with kidney failure on dialysis: factor XI as a therapeutic target.
100:1199-1207.
2021
-
A genome-wide association study suggests correlations of common genetic variants with peritoneal solute transfer rates in patients with kidney failure receiving peritoneal dialysis.
100:1101-1111.
2021
-
A prospective cohort study of acute kidney injury and kidney outcomes, cardiovascular events, and death.
99:456-465.
2021
-
Evaluating multiple living kidney donor candidates simultaneously is more cost-effective than sequentially.
98:1578-1588.
2020
-
Potassium homeostasis and management of dyskalemia in kidney diseases: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.
97:42-61.
2020
-
The caveolin-1 regulated protein follistatin protects against diabetic kidney disease.
96:1134-1149.
2019
-
Heart failure in chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.
95:1304-1317.
2019
-
The Fracture Risk Assessment Tool (FRAX®) predicts fracture risk in patients with chronic kidney disease.
95:447-454.
2019
-
Grams ME, Sang Y, Ballew SH, et al, for the Chronic Kidney Disease Prognosis Consortium. Predicting timing of clinical outcomes in patients with chronic kidney disease and severely decreased glomerular filtration rate. Kidney Int. 2018;93:1442–1451.
94:1025-1026.
2018
-
The Authors Reply.
92:767-767.
2017
-
Challenges in conducting clinical trials in nephrology: conclusions from a Kidney Disease—Improving Global Outcomes (KDIGO) Controversies Conference.
92:297-305.
2017
-
The association of anticoagulation, ischemic stroke, and hemorrhage in elderly adults with chronic kidney disease and atrial fibrillation.
91:928-936.
2017
-
Acute change in glomerular filtration rate with inhibition of the renin-angiotensin system does not predict subsequent renal and cardiovascular outcomes.
91:683-690.
2017
-
Patients receiving frequent hemodialysis have better health-related quality of life compared to patients receiving conventional hemodialysis.
91:746-754.
2017
-
Plasmapheresis for the treatment of kidney diseases.
90:974-984.
2016
-
Application of new acute kidney injury biomarkers in human randomized controlled trials.
89:1372-1379.
2016
-
Advanced chronic kidney disease populations have elevated trimethylamine N-oxide levels associated with increased cardiovascular events.
89:1144-1152.
2016
-
Recommendations for kidney disease guideline updating: a report by the KDIGO Methods Committee.
89:753-760.
2016
-
Preservation of residual kidney function in hemodialysis patients: reviving an old concept.
90:262-271.
2016
-
Treatment frequency and mortality among incident hemodialysis patients in the United States comparing incremental with standard and more frequent dialysis.
90:1071-1079.
2016
-
Comparison of standard and accelerated initiation of renal replacement therapy in acute kidney injury.
88:897-904.
2015
-
Perioperative heart-type fatty acid binding protein is associated with acute kidney injury after cardiac surgery.
88:576-583.
2015
-
Modifiable lifestyle and social factors affect chronic kidney disease in high-risk individuals with type 2 diabetes mellitus.
87:784-791.
2015
-
Endothelin-1, but not angiotensin II, induces afferent arteriolar myosin diphosphorylation as a potential contributor to prolonged vasoconstriction.
87:370-381.
2015
-
A systematic review of the role of C4d in the diagnosis of acute antibody-mediated rejection.
87:182-194.
2015
-
Reducing hospital readmissions in patients with end-stage kidney disease.
88:1250-1260.
2015
-
The relationship between estimated sodium and potassium excretion and subsequent renal outcomes.
86:1205-1212.
2014
-
The three-year incidence of fracture in chronic kidney disease.
86:810-818.
2014
-
End-stage renal disease in living kidney donors.
86:20-22.
2014
-
KDIGO Clinical Practice Guideline for Lipid Management in CKD: summary of recommendation statements and clinical approach to the patient.
85:1303-1309.
2014
-
Biocompatible peritoneal dialysis solutions: many questions but few answers.
84:864-866.
2013
-
Nephrologist follow-up improves all-cause mortality of severe acute kidney injury survivors.
83:901-908.
2013
-
A multinational cohort study of in-center daily hemodialysis and patient survival.
83:300-307.
2013
-
Oral bisphosphonate use in the elderly is not associated with acute kidney injury.
82:903-908.
2012
-
The effect of frequent hemodialysis on nutrition and body composition: Frequent Hemodialysis Network Trial.
82:90-99.
2012
-
Reporting of the estimated glomerular filtration rate decreased creatinine clearance testing.
81:1245-1247.
2012
-
Reporting of the estimated glomerular filtration rate was associated with increased use of angiotensin-converting enzyme inhibitors and angiotensin-II receptor blockers in CKD.
81:1248-1253.
2012
-
Combined intensive blood pressure and glycemic control does not produce an additive benefit on microvascular outcomes in type 2 diabetic patients.
81:586-594.
2012
-
Early postoperative serum cystatin C predicts severe acute kidney injury following pediatric cardiac surgery.
80:655-662.
2011
-
Lower estimated glomerular filtration rate and higher albuminuria are associated with all-cause and cardiovascular mortality. A collaborative meta-analysis of high-risk population cohorts.
79:1341-1352.
2011
-
The Authors Reply:.
78:112-112.
2010
-
Nephroprotective drugs from traditionally used Aboriginal medicinal plants.
77:471-472.
2010
-
Smad3-dependent and -independent pathways are involved in peritoneal membrane injury.
77:319-328.
2010
-
Results of a randomized controlled trial on statin use in dialysis patients had no influence on statin prescription.
76:1172-1179.
2009
-
Response to ‘The data on transplantation in Saudi Arabia are complex and require additional framework for interpretation’.
76:914-915.
2009
-
When laboratories report estimated glomerular filtration rates in addition to serum creatinines, nephrology consults increase.
76:318-323.
2009
-
Global trends in the rates of living kidney donation.
75:1088-1098.
2009
-
Nocturnal hemodialysis does not improve overall measures of quality of life compared to conventional hemodialysis.
75:542-549.
2009
-
Development of end stage renal disease following an acute cardiac event.
74:356-363.
2008
-
Plasma exchange for myeloma kidney: cast(s) away?.
73:1211-1213.
2008
-
Chronic kidney disease and postoperative mortality: A systematic review and meta-analysis.
73:1069-1081.
2008
-
Differences in tolerance for health risk to the living donor among potential donors, recipients, and transplant professionals.
73:1159-1166.
2008
-
Acute kidney injury: Better biomarkers and beyond.
73:801-803.
2008
-
Critical issues related to real-time fluorescence imaging of renal tissues using confocal microscopy.
73:656-656.
2008
-
Response to ‘Chronically decreased GFR and cardiovascular risk in living kidney donors’.
73:509-510.
2008
-
Studying channel and receptor physiology in podocytes.
73:364-364.
2008
-
Increased mortality in hemodialysis patients having specific antibodies to the platelet factor 4-heparin complex.
73:213-219.
2008
-
Improving on-line information for potential living kidney donors.
71:1062-1070.
2007
-
Response to ‘Reduced kidney function in living donors’.
71:1077-1077.
2007
-
When to refer patients with chronic kidney disease for vascular access surgery: Should age be a consideration?.
71:555-561.
2007
-
Frequent Hemodialysis Network (FHN) randomized trials: Study design.
71:349-359.
2007
-
Homocysteine induces mesangial cell apoptosis via activation of p38-mitogen-activated protein kinase.
71:304-311.
2007
-
Lost in publication: Half of all renal practice evidence is published in non-renal journals.
70:1995-2005.
2006
-
Proteinuria and reduced kidney function in living kidney donors: A systematic review, meta-analysis, and meta-regression.
70:1801-1810.
2006
-
Improvements in cognition in patients converting from thrice weekly hemodialysis to nocturnal hemodialysis: A longitudinal pilot study.
70:956-962.
2006
-
Absence of renal sequelae after childhood Escherichia coli O157:H7 gastroenteritis.
70:807-812.
2006
-
Reply from the Authors.
68:2914-2914.
2005
-
A systematic review of the effect of nocturnal hemodialysis on blood pressure, left ventricular hypertrophy, anemia, mineral metabolism, and health-related quality of life.
67:1500-1508.
2005
-
Insulin-like growth factors inhibit podocyte apoptosis through the PI3 kinase pathway.
67:1308-1314.
2005
-
Microalbuminuria three years after recovery from Escherichia coli O157 hemolytic uremic syndrome due to municipal water contamination.
67:1476-1482.
2005
-
Activation of mesangial cell MAPK in responseto homocysteine.
66:733-745.
2004
-
Effects of vitamin E on cardiovascular outcomes in people with mild-to-moderate renal insufficiency: Results of the HOPE Study.
65:1375-1380.
2004
-
Estimating the prevalence of renal insufficiency in seniors requiring long-term care.
65:649-653.
2004
-
Albuminuria and renal insufficiency prevalence guides population screening.
64:760-761.
2003
-
Albuminuria and renal insufficiency prevalence guides population screening.
64:761-762.
2003
-
Distinct distribution of specific members of protein 4.1 gene family in the mouse nephron.
63:1321-1337.
2003
-
Renal insufficiency and the risk of cardiovascular mortality.
62:1474-1474.
2002
-
Reply from the Authors.
62:1474-1475.
2002
-
Albuminuria and renal insufficiency prevalence guides population screening: Results from the NHANES III.
61:2165-2175.
2002
-
Moderate renal insufficiency and the risk of cardiovascular mortality: Results from the NHANES I.
61:1486-1494.
2002
-
Association between renal insufficiency and malnutrition in older adults: Results from the NHANES III.
60:1867-1874.
2001
-
Risk of bacteremia from temporary hemodialysis catheters by site of insertion and duration of use: A prospective study.
58:2543-2545.
2000
-
Preservation of glomerular filtration rate on dialysis when adjusted for patient dropout.
57:691-696.
2000
-
Stretch activation of Jun N-terminal kinase/stress-activated protein kinase in mesangial cells.
58:1431-1439.
2000
-
Nitric oxide modulates stretch activation of mitogen-activated protein kinases in mesangial cells.
58:1067-1077.
2000
-
Mesangial cell signaling cascades in response to mechanical strain and glucose.
56:1721-1728.
1999
-
Activation of mesangial cell signaling cascades in response to mechanical strain.
55:476-485.
1999
-
Carbamylated hemoglobin and carbamylated plasma protein in hemodialyzed patients.
53:488-495.
1998
-
Dietary supplementation with L-arginine limits cell proliferation in the remnant glomerulus.
48:1857-1865.
1995
-
A controlled trial of cyclosporine in patients with progressive membranous nephropathy.
47:1130-1135.
1995
-
Fish oil in lupus nephritis: Clinical findings and methodological implications.
44:75-86.
1993
-
Omega-3 fatty acid dietary supplementation in systemic lupus erythematosus.
36:653-660.
1989
-
Effects of hemodialysis and hypertonic hemodiafiltration on cardiac function compared.
32:399-407.
1987
-
Prognosis of adult onset polycystic kidney disease re-evaluated.
26:190-193.
1984
-
Noninvasive monitoring of renal transplant function by analysis of beta2-microglobulin.
23:767-770.
1983
-
In vivo platelet activation with in vitro hyperaggregability to arachidonic acid in renal allograft recipients.
23:506-513.
1983
-
In vivo platelet activation with in vitro hyperaggregability to arachidonic acid in renal allograft recipients..
23:506-513.
1983
-
Experimental nephritis associated with plasmodium infection in mice.
16:53-63.
1979
-
Genetics in chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference
2022
-
Chronic kidney disease and arrhythmias: highlights from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference
2018
-
Flaxseed: A potential treatment for lupus nephritis
1995
-
MORBIDITY IN CHRONIC-HEMODIALYSIS PATIENTS - A STUDY OF PROGNOSIS
1990
-
THE PRESYMPTOMATIC DIAGNOSIS OF AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY-DISEASE (ADPKD)
1990
-
THE PROGNOSIS OF AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY-DISEASE - PKD-1 VS PKD2
1990
-
OMEGA-3 FATTY-ACID DIETARY SUPPLEMENTATION IN LUPUS NEPHRITIS
1989
-
RANDOMIZED CLINICAL-TRIAL (RCT) COMPARING PERITONITIS RATES AMONG NEW CAPD PATIENTS USING THE Y-SET DISINFECTANT SYSTEM (Y) TO STANDARD SYSTEMS (S)
1989
-
PERITONITIS IN CAPD PATIENTS-A RANDOMIZED CLINICAL-TRIAL (RCT) OF TRIMETHOPRIM-SULFAMETHOXAZOLE (TMP/SMX) PROPHYLAXIS
1988
-
REVERSAL OF PROTEINURIA AND REDUCTION OF MORTALITY IN NZB/W F1 LUPUS MICE BY PROSTAGLANDIN-E1 (PGE1), ILOPROST AND A THROMBOXANE SYNTHASE INHIBITOR (TSI)
1988
-
THE PRIMARY DETERMINANT OF ONE YEAR GRAFT-SURVIVAL OF CADAVER KIDNEY-TRANSPLANTS IS EARLY RENAL-FUNCTION
1988
-
PROSTAGLANDINS IN EXPERIMENTAL LUPUS NEPHRITIS
1987
-
REUSE OF DIALYZERS - A MULTIPLE CROSSOVER TRIAL WITH RANDOM ALLOCATION TO TREATMENT ORDER
1987
-
COMPLICATIONS RELATED TO THE ROUTE OF MINNESOTA ANTILYMPHOBLAST GLOBULIN (MALG) ADMINISTRATION IN RENAL-TRANSPLANT RECIPIENTS
1985
-
PRE-NATAL DIAGNOSIS OF KIDNEY DISORDERS BY ULTRASOUND
1985
-
SEQUENTIAL MINNESOTA ANTILYMPHOBLAST GLOBULIN (MALG) AND (CY) THERAPY AFTER CADAVER RENAL-TRANSPLANTATION
1985
-
ADULT POLYCYSTIC KIDNEY-DISEASE (APKD) - REAPPRAISAL OF PROGNOSIS
1984
-
CARPAL-TUNNEL SYNDROME IN DIALYSIS PATIENTS
1984
-
EFFECTIVENESS OF THIAZIDES IN PREVENTING RECURRENT CALCIUM UROLITHIASIS - THE QUALITY OF THE EVIDENCE
1983
-
BONE FLUORIDE IN RENAL OSTEODYSTROPHY
1982
-
KIDNEY-STONE ANALYSIS BY INFRARED-SPECTROSCOPY AS A PREDICTOR OF URINE CHEMISTRY
1981
-
POLYCYSTIC KIDNEY-DISEASE (PKD) AND GENETIC-MARKERS
1981
-
PLATELET-AGGREGATING IMMUNE-COMPLEXES IN IDIOPATHIC GLOMERULO-NEPHRITIS AND LUPUS NEPHRITIS
1980
-
UROLITHIASIS (U) - ENVIRONMENTAL AND GENETIC-FACTORS
1979
-
UROLITHIASIS (U) - ENVIRONMENTAL AND GENETIC FACTORS
1978
-
HYPERTENSION, HYPERRENINEMIA AND UNILATERAL RENAL-ARTERY OCCLUSION
1977
has subject area
Identity
International Standard Serial Number (ISSN)
Electronic International Standard Serial Number (EISSN)